Communications
E. F. Hounsell, N. Jayaraman, T. M. Nilsen, N. Spencer, J. F.
Stoddart, M. Young, J. Org. Chem. 1998, 63, 3429 – 3437.
[7] Several glycosylated cyclodextrins have been prepared with the
aim of combining both the inclusion capabilities of the hydro-
phobic cavity inherent in the cyclomalto-oligosaccharide struc-
ture and the biological receptor binding ability of oligosacchar-
ides; for examples, see: a) C. Ortiz Mellet, J. Defaye, J. M.
García Fernµndez, Chem. Eur. J. 2002, 8, 1982 – 1990; b) D. A.
Fulton, J. F. Stoddart, Bioconjugate Chem. 2001, 12, 655 – 672;
c) A. Vargas-Berenguel, F. Ortega-Caballero, F. Santoyo-Gon-
zµlez, J. J. García-López, J. J. GimØnez-Martínez, L. García-
Fuentes, E. Ortiz-Salmerón, Chem. Eur. J. 2002, 8, 812 – 827;
d) T. Yamanoi, N. Yoshida, Y. Oda, E. Akaike, M. Tsutsumida,
N. Kobayashi, K. Osumi, K. Yamamoto, K. Fujita, K. Takahashi,
K. Hattori, Bioorg. Med. Chem. Lett. 2005, 15, 1009 – 1013; e) H.
Abe, A. Kenmoku, N. Yamaguchi, K. Hattori, J. Inclusion
Phenom. Macrocyclic Chem. 2002, 44, 39 – 47.
depleted after addition of an appropriate AC scavenger
(Figure 1B, right-to-left). The trimeric a,a’-trehalose-based
receptor CT3, which exhibits a perfect size match and
[20]
symmetry complementarity with AC (Kass = 4.6 104 mÀ1
)
was considered a good candidate for this purpose. Addition of
1.5 equivalents of CT3 per mol of effector molecule to AC-
activated samples of 2 or 3 led the system backto the initial
state—switch “off”—in agreement with the reversible char-
acter of the equilibria involved both at the lectin binding site
and in the CD cavity.[21]
In summary, our results indicate that reversible tuning and
switching of the binding affinity in a model carbohydrate–
lectin system is possible through logical design. This workhas
included the first examples of allosteric activation/deactiva-
tion of binding and of the multivalent effect. This switchable,
environment-sensitive, supramolecularly mediated carbohy-
drate–protein recognition offers exciting possibilities to
mimic biological processes involving effector/antagonist mol-
ecules. Indeed, specific drug delivery using CD conjugates is
hampered by the blocking of the protein receptors by
unoccupied carriers, which might be avoided by designing
switchable systems for which the drug will act as the effector
(input “on”). We aim to investigate this possibility, as well as
the further supramolecular modulation of multivalent inter-
actions through variations in chemical modification in this
and other systems.
[8] I. Willner, Acc. Chem. Res. 1997, 30, 347 – 356, and references
therein.
[9] a) J. M. Benito, M. Gómez-García, C. Ortiz Mellet, I. Baus-
sanne, J. Defaye, J. M. García Fernµndez, J. Am. Chem. Soc.
2004, 126, 10355 – 10366; b) I. Baussanne, J. M. Benito, C.
Ortiz Mellet, J. M. García Fernµndez, J. Defaye, ChemBioChem
2001, 2, 777 – 783.
[10] F. Djedaïni-Pilard, N. Azaroual-Bellanger, M. Gosnat, D.
Vernet, B. Perly, J. Chem. Soc. Perkin Trans. 2 1995, 723 – 730.
[11] D. Yockot, V. Moreau, G. Demailly, F. Djedaïni-Pilard, Org.
Biomol. Chem. 2003, 1, 1810 – 1818.
[12] a) J. Bouckaert, T. Hamelryck, L. Wyns, R. Loris, Curr. Opin.
Struct. Biol. 2001, 11, 635 – 643; b) H. Lis, N. Sharon, Chem. Rev.
1998, 98, 637 – 674.
Received: March 22, 2006
Revised: June 7, 2006
Published online: July 20, 2006
[13] R. AuzØly-Velty, B. Perly, O. TachØ, T. Zemb, P. JØhan, P.
Guenot, J.-P. Dalbiez, F. Djedaïni-Pilard, Carbohydr. Res. 1999,
318, 82 – 90.
[14] N. Smiljanic, S. Halila, V. Moreau, F. Djedaïni-Pilard, Tetrahe-
dron Lett. 2003, 44, 8999 – 9002.
[15] M. K. Anwer, A. F. Spatola, Tetrahedron Lett. 1981, 22, 4369 –
4372.
[16] M. V. Rekharsky, Y. Inoue, Chem. Rev. 1998, 98, 1875 – 1917.
[17] J. Lin, F. Djedaïni-Pilard, P. GuØnot, B. Perly, Supramol. Chem,
1996, 7, 175 – 181.
[18] The terms minicluster (microcluster) and macrocluster effect
have been used previously in the literature to refer to the
observed increases in lectin-binding affinities for small glyco-
clusters and large glycopolymers, respectively; see: a) M. S.
Quesenberry, R. T. Lee, Y. C. Lee, Biochemistry 1997, 36, 2724 –
2732; b) J.-Q. Fan, M. S. Quesenberry, K. Takegawa, S. Iwahara,
A. Kondo, I. Kato, Y. C. Lee, J. Biol. Chem. 1995, 270, 17730 –
17735.
[19] For recent evidence on the the existence of an aggregation-
independent microcluster effect, see: M. Kꢀhn, J. M. Benito, C.
Ortiz Mellet, T. K. Lindhorst, J. M. García Fernµndez, Chem-
BioChem 2004, 5, 771 – 777.
Keywords: carbohydrates · cyclodextrins · lectins ·
noncovalent interactions · receptors
.
[1] a) H.-H. Gabius, H.-C. Siebert, S. AndrØ, J. JimØnez-Barbero, H.
Rüdiger, ChemBioChem 2004, 5, 740 – 764; b) T. K. Dam, C. F.
Brewer, Chem. Rev. 2002, 102, 387 – 429; c) C. R. Bertozzi, L. L.
Kiessling, Science 2001, 291, 2357 – 2364.
[2] a) M. Mamen, S.-K. Choi, G. M. Whitesides, Angew. Chem. 1998,
110, 2908 – 2953; Angew. Chem. Int. Ed. 1998, 37, 2754 – 2794;
b) J. J. Lundquist, E. J. Toone, Chem. Rev. 2002, 102, 555 – 578.
[3] a) Y. C. Lee, R. T. Lee, Acc. Chem. Res. 1995, 28, 321 – 327;
b) Y. C. Lee, R. T. Lee, Glycoconjugate J. 2000, 17, 543 – 551.
[4] a) N. Horan, H. Isobe, G. M. Whitesides, D. Kahne, Proc. Natl.
Acad. Sci. USA 1999, 96, 11782 – 11786; b) J. E. Gestwicki, C. W.
Cairo, L. E. Strong, K. A. Oetjen, L. L. Kiessling, J. Am. Chem.
Soc. 2002, 124, 14922 – 14933; c) E. K. Soller, E. D. Walter, J. R.
Morgan, D. J. Singel, M. J. Cloninger, J. Am. Chem. Soc. 2003,
125, 8820 – 8826; d) M. Gómez-García, J. M. Benito, J.-X. Yu, K.
Chmurski, C. Ortiz Mellet, R. GutiØrrez Gallego, A. Maestre, J.
Defaye, J. M. García Fernµndez, J. Am. Chem. Soc. 2005, 127,
7970 – 7971; e) L. L. Kiessling, J. E. Gestwicki, L. E. Strong,
Angew. Chem. 2006, 118, 2408 – 2429; Angew. Chem. Int. Ed.
2006, 45, 2348 – 2368.
[5] a) M. J. Cloninger, Curr. Opin. Chem. Biol. 2002, 6, 742 – 748;
b) W. B. Turnbull, J. F. Stoddart, Rev. Mol. Biotechnol. 2002, 90,
231 – 255; c) T. K. Lindhorst, Top. Curr. Chem. 2002, 218, 201 –
235.
[6] For pioneering workon the evaluation of the influence of
conformational crowding in carbohydrate–protein binding affin-
ity using dendrimer-centred glycoligands, see: a) D. Page, R.
Roy, Bioconjugate Chem. 1997, 8, 714 – 723; b) P. R. Ashton,
[20] J. M. Benito, J. L. JimØnez Blanco, C. Ortiz Mellet, J. M. García
Fernµndez, Angew. Chem. 2002, 114, 3826 – 2828; Angew. Chem.
Int. Ed. 2002, 41, 3674 – 3676.
[21] Control ELLA experiments demonstrated that CT3 does not
interfere in the binding of the mannosyl ligands 1–3 with Con A
in the absence of AC. Binding of 1 to Con A was also unaffected
by the presence of AC and AC:CT3 in up to threefold excesses.
These results strongly support that CT3 triggers the “off” state
by a mechanism involving exclusively AC trapping. Conse-
quently, further addition of AC to a CT3-switched-off sample of
2:AC restored the “on” state in a new cycle, thus confirming the
reversibility of both input processes. NMR experiments addi-
tionally supported the absence of supramolecular interactions
between CT3 and the bCD-centred glycoligands 1–3.
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2006, 45, 5465 –5468